Vise Technologies’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
+80,641
| New | +$1.25M | 0.05% | 379 |
|
|
2024
Q4 | $459K | Buy |
34,635
+1,026
| +3% | +$13.6K | 0.04% | 464 |
|
|
2024
Q3 | $478K | Buy |
33,609
+9,387
| +39% | +$133K | 0.06% | 312 |
|
|
2024
Q2 | $313K | Sell |
24,222
-2,631
| -10% | -$34K | 0.06% | 302 |
|
|
2024
Q1 | $373K | Buy |
26,853
+1,830
| +7% | +$25.4K | 0.07% | 251 |
|
|
2023
Q4 | $357K | Buy |
25,023
+449
| +2% | +$6.41K | 0.08% | 236 |
|
|
2023
Q3 | $380K | Sell |
24,574
-1,303
| -5% | -$20.2K | 0.09% | 209 |
|
|
2023
Q2 | $407K | Sell |
25,877
-8,156
| -24% | -$128K | 0.1% | 202 |
|
|
2023
Q1 | $561K | Buy |
34,033
+3,674
| +12% | +$60.5K | 0.15% | 149 |
|
|
2022
Q4 | $474K | Sell |
30,359
-890
| -3% | -$13.9K | 0.15% | 156 |
|
|
2022
Q3 | $405K | Buy |
31,249
+10,390
| +50% | +$135K | 0.15% | 164 |
|
|
2022
Q2 | $293K | Buy |
20,859
+9,464
| +83% | +$133K | 0.11% | 202 |
|
|
2022
Q1 | $163K | Buy |
+11,395
| New | +$163K | 0.06% | 246 |
|